CYDY
CytoDyn Inc

7,112
Mkt Cap
$414.38M
Volume
851,789.00
52W High
$0.4945
52W Low
$0.1051
PE Ratio
-17.73
CYDY Fundamentals
Price
$0.3227
Prev Close
$0.3272
Open
$0.3294
50D MA
$0.2803
Beta
0.49
Avg. Volume
2.13M
EPS (Annual)
$0.0018
P/B
-4.08
Rev/Employee
$0.00
Loading...
Loading...
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Cytodyn Inc?
What is the 52-week high for Cytodyn Inc?
What is the 52-week low for Cytodyn Inc?
What is Cytodyn Inc stock price today?
What was Cytodyn Inc stock price yesterday?
What is the PE ratio of Cytodyn Inc?
What is the Price-to-Book ratio of Cytodyn Inc?
What is the 50-day moving average of Cytodyn Inc?
How many employess does Cytodyn Inc has?

Latest CYDY News

View
No CYDY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.